BioMarin Pharmaceutical Inc.
BioMarin Announces Pricing of Public Offering of $282.5 Million Senior Subordinated Convertible Notes
Published in Law and Health Weekly, May 5th, 2007
BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced that it has agreed to sell $282.5 million aggregate principal amount of its 1.875% senior subordinated convertible notes due 2017 in an underwritten public offering. The Company has also granted the underwriter a 13-day option to purchase up to an additional $42.375 million of notes to cover over-allotments. The notes will be convertible by holders into shares of the Company's common stock at an initial conversion rate of 49.1171 shares of common stock per $1,000 principal amount of notes (subject to adjustment in certain circumstances), which represents an initial conversion price of approximately $20.36 per share. The Company...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- ACS, Inc.
ACS EDI Gateway Receives Electronic Healthcare Accreditation From Independent Agency - Alexza Pharmaceuticals, Inc.
Alexza Pharmaceuticals Announces Public Offering of Common Stock - Analysis Group, Inc.
Analysis Group Releases Report on Impact of Authorized Generic Entry on Paragraph IV Certifications - Anesthesia
Penalty Against Physicians' Group Grows to $8.6 Million; Wrongful Firing Led to Slander, Breach of Contract Complaints - Autism
Reps. Doyle, Smith, Engel and Pickering Introduce House Version of Expanding the Promise for Individuals with Autism Act - Behavior
Deloitte & Touche USA Survey Finds Strong Relationship Between Work-Life Balance and Ethical Behavior - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
